Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Diluted EPS of $1.73 per share for fiscal year 2025.
COLLEGIUM PHARMACEUTICAL, INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.73 | -7.0% |
| 2024 | $1.86 | +44.2% |
| 2023 | $1.29 | +274.3% |
| 2022 | -$0.74 | -139.8% |
| 2021 | $1.86 | +144.7% |
| 2020 | $0.76 | +211.8% |
| 2019 | -$0.68 | +42.9% |
| 2018 | -$1.19 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.84 | +211.1% | +147.1% |
| June 30, 2025 | $0.34 | -34.6% | +385.7% |
| March 31, 2025 | $0.07 | -90.1% | -74.1% |
| September 30, 2024 | $0.27 | -49.1% | -48.1% |
| June 30, 2024 | $0.52 | +52.9% | -26.8% |
| March 31, 2024 | $0.71 | +239.2% | +34.0% |
| September 30, 2023 | $0.53 | +5200.0% | +55.9% |
| June 30, 2023 | $0.34 | +326.7% | +166.7% |
- COLLEGIUM PHARMACEUTICAL, INC showed a decrease of -7.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, COLLEGIUM PHARMACEUTICAL, INC’s diluted eps has grown by 245.4% (from $1.19 per share (loss) to $1.73 per share).
- The most recent figure is from COLLEGIUM PHARMACEUTICAL, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: